Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Marta Davila Image

      Marta Davila, MD, AGAF, FACG, FASGE

      Department of Gastroenterology Hepatology and Nutrition, Division of Internal Medicine

      Present Title & Affiliation

      Primary Appointment

      Professor, Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor, Gastroenterology and Hepatology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor, Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1988Harvard Medical School, Boston, Massachusetts, US, MD
      1984University of California Davis, Davis, California, US, Biological Sciences, Cum Laude with Highest Honors, BS

      Postgraduate Training

      1993-1994Fellowship in Gastroenterology, Advanced therapeutic endoscopy, University of California San Francisco, San Francisco, California
      1991-1993Fellowship in Gastroenterology, University of California San Francisco, San Francisco, California
      1988-1991Residency, Internal Medicine, University of California San Francisco, San Francisco, California

      Licenses & Certifications

      2005Texas Medical Board
      1993American Board of Internal Medicine in the Subspecialty of Gastroenterology
      1991American Board of Internal Medicine
      1989Medical Board of California
      1989National Board of Medical Examiners

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2010

      Assistant Professor, Stanford University School of Medicine, Stanford, CA, 1997 - 2004

      Acting Asst. Professor, Stanford University School of Medicine, Stanford, CA, 1995 - 1997

      Assistant Clinical Professor, University of California San Francisco, San Francisco VA Medical Center, San Francisco, CA, 1994 - 1995

      Clinical Instructor, University of California San Francisco, San Francisco, CA, 1993 - 1994

      Administrative Appointments/Responsibilities

      Chair, Barrett's Section, Gastroenterology and Hepatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present

      Patient Experience Officer, Gastroenterology and Hepatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

      Chair Ad-Interim, Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2016

      Medical Director Endoscopy Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2016

      Interim Director - Clinical Outpatient Activities, Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2013

      Associate Medical Director, Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2015

      Faculty Advisor, Mid-Level Providers, Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2014

      Associate Program Director, Advanced Therapeutic Endoscopy Fellowship Program, Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2018

      Deputy Chair ad interim, Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2009

      Acting Director of Endoscopy, Stanford Hospital and Clinics, Stanford, CA, 1998 - 2000

      Other Professional Positions

      Member, Chair Search Advisory Committee, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - 2024

      Member, Data Literacy Group, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present

      Member, Moderate Sedation Task Force, MD Anderson Cancer Center, Houston, TX, 2022

      Member, Abdominal Imaging Chair Search Committee, MD Anderson Cancer Center, Houston, TX, 2022

      Member, Faculty Career Development Leads, MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Member, Leadership Team - Gastroenterology, Hepatology and Nutrition Department, MD Anderson Cancer Center, Houston, TX, 2012 - 2015

      Chair, Parenteral and Enteral Nutrition Committee, Stanford University School of Medicine, Stanford, CA, 2003 - 2004

      Member, Gastroenterology Fellows' Clinical Evaluation Committee, Stanford University School of Medicine, Stanford, CA, 1999 - 2004

      Member, Subspecialty Curriculum Committee, Stanford University School of Medicine, Stanford, CA, 1999 - 2004

      Applicant interviewer and file reviewer, Stanford University School of Medicine Admissions, Stanford University School of Medicine, Stanford, CA, 1998 - 2002

      Chair, Endoscopy Advisory Committee, Stanford University School of Medicine, Stanford, CA, 1998 - 2000

      Applicant Interviewer and File Reviewer Internal Medicine Residency Program, Stanford University School of Medicine, Stanford, CA, 1997 - 2000

      Member, Parenteral and Enteral Nutrition Committee, Stanford University School of Medicine, Stanford, CA, 1996 - 2002

      Extramural Institutional Committee Activities

      Vice-Chair, Bylaws Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Bylaws Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Chair, Senior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2022

      Member, Senior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, Executive Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2019 - 2022

      Chair, Sedation and Procedures Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2022

      Chair, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019

      Member, Faculty Career Tracks Task Force of Operational Priority #4, The University of Texas MD Anderson Cancer Center, 2018 - 2019

      Member, Clinical and Research Point Systems for Progress Review, Operational Priority #4, The University of Texas MD Anderson Cancer Center, 2018 - 2019

      Vice-Chair, Sedation and Procedures Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019

      Vice-Chair, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2017 - 2018

      Member, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2018

      Member, Sedation & Procedures Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

      Chair, Endoscopy Center Steering Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2016

      Alternative representative, Medical Staff Credentials Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2015

      Program Chair, Division of Internal Medicine and Cancer Survivorship Grand Rounds, The University of Texas MD Anderson Cancer Center, 2010 - 2014

      Member, Hepatocellular Carcinoma Screening Project, The University of Texas MD Anderson Cancer Center, 2009 - 2013

      Member, Hepatitis B screening workgroup Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2012

      Member, Division of Internal Medicine and Cancer Survivorship Grand Rounds, The University of Texas MD Anderson Cancer Center, 2007 - 2010

      Honors & Awards

      2022 - PresentTop Performer MD Anderson Award, MD Anderson Cancer Center
      2017 - 2020Top Performer MD Anderson Award, MD Anderson Cancer Center
      2012Division of Internal Medicine Leadership & Education Award, MD Anderson Cancer Center
      1993 - 1994National Research Service Award, NIH
      1984Phi Kappa Phi Honor Society
      1982 - 1984Regents Scholarship, University of California Davis

      Professional Memberships

      American College of Gastroenterology

      2018 - 2025

      American College of Gastroenterology

      2016 - 2023

      American College of Gastroenterology

      2013 - 2016

      American Society for Gastrointestinal Endoscopy

      2010 - Present

      American Society for Gastrointestinal Endoscopy

      2010 - 2013

      American College of Gastroenterology

      2009 - 2013

      Texas Society for Gastroenterology and Endoscopy

      2009 - 2013

      American College of Gastroenterology

      2008 - Present

      Texas Society for Gastroenterology and Endoscopy (TSGE)

      2008 - Present

      American Gastroenterological Association

      2008 - Present

      Harris County Medical Society

      2007 - Present

      Texas Medical Association

      2007 - Present

      American Society for Gastrointestinal Endoscopy

      2005 - Present

      American Cancer Society

      2000 - 2001

      California Hispanic American Medical Association

      1989 - 2000

      Selected Presentations & Talks

      Local Presentations

      1. 2026. GERD and Barrett’s esophagus – Current guidelines. GI Fellows Didactics Session. Houston, Texas, US.
      2. 2026. Endoscopic management of Barrett’s esophagus and early esophageal cancer. Thoracic Cancer Care Course. Houston, Texas, US.
      3. 2025. Management of GERD patients and Endoscopic management of Barrett’s esophagus. GI Fellows Didactics Session. Houston, Texas, US.
      4. 2024. Celiac Disease, Ileus, and Acute colonic pseudo-obstruction. GI Fellows Didactics Session. Houston, Texas, US.
      5. 2023. Endoscopic management of Barrett’s esophagus and early esophageal cancer. Conference. GHSGNA. Houston, TX, US.
      6. 2019. Video GIE Case Based Learning from the Experts. Conference. Texas Society for Gastroenterology and Endoscopy. Houston, TX, US.
      7. 2011. Capsule Endoscopy in 2011. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      8. 2009. Screening for Hepatocellular carcinoma. Conference. Health Education for Asians League of Houston. Houston, TX, US.

      Regional Presentations

      1. 2015. Update on wireless capsule endoscopy. Conference. Texas Society for Gastroenterology and Endoscopy (TSGE). Ft. Worth, TX, US.
      2. 2008. Modifying Risk Factors for HCC in Patients with Viral Hepatitis and Cirrhosis. Conference. UT-MD Anderson Cancer Center. San Antonio, TX, US.
      3. 2008. Recent Advances in Colonic Imaging - New colonoscopic techniques. Conference. UT-MD Anderson Cancer Center. San Antonio, TX, US.

      National Presentations

      1. 2025. ASGE Virtual Masterclass Endoquest: Endoscopy in the GI Unit for Nurses and Technicians. Invited. ASGE, US.
      2. 2022. Best of ACG 2021: Outstanding Science, Expert Discussions. Invited. American College of Gastroenterology Virtual Grand Rounds, US.
      3. 2020. Hands-On EMR program, Second Year Fellows Course. Conference. American College of Gastroenterology (ACG). Washington, DC, US.
      4. 2018. The University of Texas MD Anderson Cancer Center. Department of Anesthesiology and Perioperative Medicine Grand Rounds. Faculty Promotions: Insight from CFRC Leadership and recently promoted Faculty. Conference. MD Anderson Cancer Center. Houston, TX, US.
      5. 2018. Grand Rounds, Faculty Promotions: Insight from CFRC Leadership and recently promoted Faculty. Invited. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      6. 2018. CFRC Promotion and Tenure Panel. Conference. Clinical Faculty Review Committee. Houston, TX, US.
      7. 2015. Endoscopy in Liver Disease. Invited. AASLD. San Francisco, CA, US.
      8. 2011. Introduction to Capsule Endoscopy. Invited. Digestive Disease Week. Chicago, IL, US.
      9. 2010. Introduction to Capsule Endoscopy. Invited. Digestive Disease Week. New Orleans, LA, US.
      10. 2009. The Role of Capsule endoscopy in the management of obscure GI bleeding. Invited. American College of Gastroenterology. San Diego, CA, US.
      11. 2006. Complications following endoscopic stent placement for malignant biliary obstruction: preliminary analysis. Conference. Digestive Disease Week. Los Angeles, CA, US.
      12. 2005. Endoscopic Ultrasound-guided fine needle aspiration of pancreatic duct fluid in the evaluation of pancreatic cancer. Conference. Digestive Disease Week. Chicago, IL, US.
      13. 2002. The experience at a tertiary care referral center. Conference. American Gastroenterological Association meeting. San Francisco, CA, US.
      14. 1998. Gastroesophageal Reflux Disease (GERD) in patients with and without Endoscopic Abnormalities: Age and Gender differences. Conference. American Gastroenterological Association. New Orleans, LA, US.
      15. 1994. Endoscopic Management of Refractory High-Grade Proximal Esophageal Strictures following Surgery and Radiation for Head and Neck Malignancies. Conference. American College of Gastroenterology. San Francisco, CA, US.
      16. 1994. The detection of Small Bowel tumors with a Flexible Tip Video Enteroscope. Conference. American College of Gastroenterology. San Francisco, CA, US.
      17. 1994. Early experience with a High Resolution Small Diameter Per-Oral Cholangioscope. Conference. American College of Gastroenterology. San Francisco, CA, US.

      International Presentations

      1. 2013. Role of the nurse in preparation to stenting of stenosis in esophageal cancer. Invited. OESO. Paris, FR.
      2. 2013. In anastomotic leaks after esophagectomy and gastric pull-up, should endoscopic closure be attempted?. Invited. OESO. Paris, FR.
      3. 2013. Endoscopy post-esophagectomy. Invited. OESO. Paris, FR.

      Formal Peers

      1. 2023. Endoscopic Management of Barrett’s Esophagus and Early Esophageal Cancer. Visiting. Houston, TX, US.
      2. 2022. Barrett’s Esophagus. Visiting. Houston, TX, US.
      3. 2021. Physician Burnout. Visiting. Houston, TX, US.
      4. 2021. Endoscopic Management of Barrett’s esophagus and early esophageal adenocarcinoma. Visiting. Houston, TX, US.
      5. 2014. Capsule Endoscopy Interpretation. Visiting. Houston, TX, US.
      6. 2014. Barrett's Esophagus. Visiting. Houston, TX, US.
      7. 2013. Endoscopic Management of Esophageal Cancer and Barrett's with Dysplasia. Visiting. Houston, TX, US.
      8. 2012. Visualize Imaging the Small Bowel: What MR Enterography and Endoscopy Provide. Visiting. Houston, TX, US.
      9. 2011. "Stents" Challenging Cases Presentation. Visiting. Houston, TX, US.
      10. 2010. Gallstone Disease. Visiting. Houston, TX, US.
      11. 2010. Evaluation and Management in Patients with Irritable Bowel Syndrome. Visiting. Houston, TX, US.
      12. 2009. New Treatments for Barrett's. Visiting. Houston, TX, US.
      13. 2009. Screening for Hepatitis B and Treatment of Hepatitis B Reactivation among Cancer Patients. Visiting. Houston, TX, US.
      14. 2009. Early Diagnosis and Treatment of Barrett's Esophagus. Visiting. Houston, TX, US.
      15. 2008. Recent Advances in the Evaluation of Patients with Obscure GI Bleeding: The Expanding Technology of Small Bowel Imaging. Visiting. Houston, TX, US.
      16. 2008. Non Alcoholic Fatty Liver Disease. Visiting. Houston, TX, US.
      17. 2007. Hepatitis B reactivation in cancer patients. Visiting. Houston, TX, US.
      18. 2007. Photodynamic Therapy in Barrett's. Visiting. Houston, TX, US.
      19. 2007. Primary Treatment of Hepatitis B-The Paradigm Today. Visiting. Houston, TX, US.
      20. 2006. Capsule Endoscopy. Visiting. Houston, TX, US.
      21. 2006. CAPSULE presentation to Bowel Management. Visiting. Houston, TX, US.
      22. 2006. Hepatitis Reactivation in Cancer Patients. Visiting. Houston, TX, US.
      23. 2005. Reactivation of HBV in Immunosuppressed and Chemotherapy Patients. Visiting. Houston, TX, US.
      24. 2003. Gastroesophageal Reflux Disease: New Insights into treatment. Visiting, CA, US.
      25. 2003. New Insights into the treatment of Irritable bowel syndrome. Visiting, US.
      26. 2002. Screening for Colorectal Cancer. Visiting. San Jose, CA, US.
      27. 2001. Medical and Endoscopic Management of GERD and Achalasia. Visiting. San Francisco, CA, US.
      28. 2000. Endoscopic Management of Benign Esophageal Strictures and Achalasia. Invited, US.
      29. 1999. Nutritional Issues in Inflammatory Bowel Disease. Invited, US.
      30. 1999. Percutaneous Endoscopic Gastrostomy. Visiting. San Francisco, CA, US.
      31. 1996. Pancreatic Pseudocysts. Visiting. Palo Alto, CA, US.
      32. 1995. Etiology and Management of Pain in Chronic Pancreatitis. Visiting. San Francisco, CA, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2012
      Title:Esophageal Cancer Research
      Funding Source:Young Texans Against Cancer
      Role:Co-I
      Date: 2000 - 2004
      Title:Three Dimensional Spiral CT Colonography
      Funding Source:NIH
      Role:Co-I
      ID:RO1CA72023
      Title:A randomized controlled study comparing warm water infusion vs. air insufflation for colonoscopic insertion in women undergoing colonoscopy
      Funding Source:Texas Foundation of Business and Professional Women
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carlson R, Hagan K, Davila M, Stroehlein J. Cap-fitted endoscopic mucosal resection of =?20?mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate. Endosc Int Open 8(2):E115-E121, 2020. e-Pub 2020. PMID: 32010742.
      2. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with >20mm colon polyps. Endosc Int Open 7(3):E361-E366, 2019. e-Pub 2019. PMID: 30834295.
      3. Nelson DB, Dhupar R, Katkhuda R, Correa A, Goltsov A, Maru D, Sepesi B, Antonoff MB, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WL. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. J Thorac Cardiovasc Surg 156(1):406-413.e3, 2018. e-Pub 2018. PMID: 29605441.
      4. Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology 95(2):81-90, 2018. e-Pub 2018. PMID: 29843157.
      5. Chen J, Shukla V, Farci P, Andricovich J, Jogunoori W, Kwong LN, Katz LH, Shetty K, Rashid A, Su X, White J, Li L, Wang AY, Blechacz B, Raju GS, Davila M, Nguyen BN, Stroehlein JR, Chen J, Kim SS, Levin H, Machida K, Tsukamoto H, Michaely P, Tzatsos A, Mishra B, Amdur R, Mishra L. Loss of the transforming growth factor-β effector β2-Spectrin promotes genomic instability. Hepatology 65(2):678-693, 2017. e-Pub 2017.
      6. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani M, Shafi M, Weston B, Pande M, Bresalier R, Rashid A, Mishra L, Davila M, Stroehlein J. Outcome of Endoscopic Mucosal Resection As an Alternative to Surgery in Patients with Complex Colon Polyps. Gastrointest Endosc 84(2):315-25. e-Pub 2016. PMID: 26859866.
      7. Chen J, Yao ZX, Chen JS, GI YJ, Munoz NM, Kundra S, Herlong HF, Jeong YS, Goltsov A, Ohshiro K, Mistry NA, Zhang J, Su X, Choufani S, Mitra A, Li S, Mishra B, White J, Rashid A, Wang AY, Javle M, Davila J, Michaely P, Weksberg R, Hofstetter WL, Finegold MJ, Shay JW, Machida K, Tsukamoto H, Mishra L. TGF-B/B2 -spectrin/CTCF-Regulated Tumor Suppression in Human Stem Cell Disorder Beckwith-Wiedemann Syndrome. J Clin Invest 126(2):527-42, 2016. e-Pub 2016. PMID: 26784546.
      8. Chen J, Raju GS, Jogunoori W, Menon V, Majumdar A, Chen JS, Gi YJ, Jeong YS, Phan L, Belkin M, Gu S, Kundra S, Mistry NA, Zhang J, Su X, Li S, Lin SH, Javle M, McMurray JS, Rahlfs TF, Mishra B, White J, Rashid A, Beauchemin N, Weston BR, Shafi MA, Stroehlein JR, Davila M, Akbani R, Weinstein JN, Wu X, Mishra L. Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas. PLoS One 11(4):e0153933, 2016. e-Pub 2016. PMID: 27100181.
      9. Raju GS, Lum PJ, Slack RS, Thirumurthi S, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc 82(3):512-9, 2015. e-Pub 2015. PMID: 25910665.
      10. Davila ML, Hofstetter WL. Endoscopic Management of Barrett's Esophagus with High-Grade Dysplasia and Early-Stage Esophageal adenocarcinoma. Thorac Surg Clin 23(4):479-89, 2013. e-Pub 2013.
      11. Song S, Maru DM, AJani JA, Chan CH, Honjo S, Lin HK, Correa A, Hofstetter WL, Davila M, Stroehlein J, Mishra L. Loss of TGF-B adaptor B2sP activates Notch signaling and SOX9 Expression in esophageal adenocarcinoma. Cancer Res 78(2):312-4, 2013. e-Pub 2013.
      12. Song S, Maru DM, Ajani JA, Chan CH, Honjo S, Lin HK, Correa A, Hofstetter WL, Davila M, Stroehlein J, Mishra L. Loss of TGF-b adaptor B2SP activates notch signaling an d SOX9 expression in esophageal adenocarcinoma. Cancer Res 73(7):2159-69, 2013. e-Pub 2013.
      13. Lee JH, Krishna SG, Singh A, Ladha HS, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc 1(7):2159-69, 2013. e-Pub 2013.
      14. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 57(6):1177-85, 2012. e-Pub 2012.
      15. Torres HA, Adachi JA, Roach LR, Smith KM, Mahale P, Davila M, Raad II. Hepatitis C Clinic operated by Infectious Disease at a Comprehensive Cancer Center – Help is on the way. Clin Infectious Diseases 54(5):740-2, 2012. e-Pub 2012. PMID: 22322272.
      16. Kountourakis P, Ajani JA, Davila M, Lee JH, Bhutani MS, Izzo JG. Barrett's Esophagus: A Review of Biology and Therapeutic Approaches. Gastrointest Cancer Res 5(2):49-57, 2012. e-Pub 2012.
      17. Torres HA, Davila M. Reactivation of hepatitis b virus and hepatitis c virus in patients with cancer. Nat Rev Clin Oncol 9(3):156-66, 2012. e-Pub 2012.
      18. Mahale P, Kaseb AO, Davila M, Torres HA. The Effect of Transcatheter Arterial Chemoembolization on Hepatitis C Viremia. Oncologist 17(9):e21-3, 2012. e-Pub 2012.
      19. Mendelsohn J, Song S, Ying L, Mishra B, Davila M, Hofstetter W, Mishra L. Dysfunctional TGF-B signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma. Cancer 117(16):3691-702, 2011. e-Pub 2011.
      20. Welsh J, Amini A, Likhacheva A, Erasmus J, Gomez D, Davila M, Mehran R, Komaki R, Liao Z, Hofstetter WL, Bhutani M, Ajani JA. Update: Modern Approaches to the treatment of localized esophageal cancer. Curr Oncol Rep 13(3):157-67, 2011. e-Pub 2011.
      21. Raju RP, Jaganmohan SR, Ross WA, Davila ML, Javle M, Raju GS, Lee JH. Optimum Palliation of Inoperable Hilar Cholangiocarcinoma: Comparative Assessment of the Efficacy of Plastic and Self-Expanding Metal Stents. Dig Dis Sci 56(5):1557-64, 2011. e-Pub 2011. PMID: 21222156.
      22. Davila, ML. Photodynamic Therapy. Gastrointest Endoscopy Clin N Am 21(1):67-79, 2011. e-Pub 2011.
      23. Lee JH, Ross WA, Davila R, Chang G, Lin E, Dekovich A, Davila M. Self-expandable metal stents (SEMS) can serve as a bridge to surgery or as a definitive therapy in patients with an advanced stage of cancer: clinical experience of a tertiary cancer center. Dig Dis Sci 55(12):3530-6, 2010. e-Pub 2010.
      24. Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, Javle M, Moghazy D, Lozano, RD, Abbruzzese JL, Vauthey JN. Association of Diabetes Duration and Diabetes Treatment with the risk of hepatocellular carcinoma. Cancer 116(8):1938-1946, 2010. e-Pub 2010.
      25. Thomas MB, Morris JS, Chadha R, Kaur H, Iwasaki M, Lin E, Kaseb A, Glover KY, Davila M. A Phase II trial of the combination of bevacizumab and erlotinib in patients with advanced hepatocellular carcinoma. Journal of Clinical Oncology 27(6):833-5, 2009. e-Pub 2009.
      26. Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, Curley SA, Spitz MR, Sherman SI, Abdalla EK, Davila M, Lozano RD, Hassan DM, Chan W, Brown TD, Abbruzzese JL. Association Between Hypothyroidism and Hepatocellular Carcinoma: A Case-control Study in the United States. Hepatology 49(5):1563-70, 2009. e-Pub 2009.
      27. Hassan MM, Donghui L, El-Deeb AS, Wolff RA, Bonday ML, Davila M, and Abbruzzese JL. Association Between Hepatitis B Virus and Pancreatic Cancer. Journal of Clinical Oncology 26(28):4557-4562, 2008. e-Pub 2008.
      28. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davila M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 112(5):1020-1027, 2008. e-Pub 2008.
      29. Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of Endoscopic Ultrasound Staging in Conjunction with the Evaluation of Lymphovascular Invasion in Identifying Low-Risk Esophageal Carcinoma. Cancer 112(3):503-10, 2008. e-Pub 2008.
      30. Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer 109(4):668-74, 2007. e-Pub 2007.
      31. Rosa-e-Silva L, Gerson LB, Davila M, Triadafilopoulos G. Clinical, radiologic and manometric characteristics of adult chronic intestinal dysmotility: the Stanford experience. Clin Gastroenterol Hepatol 4:866-73, 2006. e-Pub 2006.
      32. Lin M, Gerson LB, Lascar R, Davila M, Triadafilopoulos G. Features of gastroesophageal reflux disease in women. Am J Gastroenterol 99:1442-7, 2004. e-Pub 2004. PMID: 15307857.
      33. Mani A, Napel S, Paik DS, Jeffrey RB, Jr, Yee J, Olcott EW, Prokesch R, Davila M, Schraedley-Desmond P, Beaulieu CF. Computed tomography colonography: feasibility of computer-aided polyp detection in a "first reader" paradigm. J Comput Assist Tomogr 28:318-26, 2004. e-Pub 2004. PMID: 15100534.
      34. Treadwell J, Kearney D, Davila M. Health Sequence Preferences of Hepatitis C patients. Dig Dis Sci 45:345-350, 2000. e-Pub 2000.
      35. Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, Morgan DR, Ostroff JW, Rockey DC, Bacchetti P, LaBerge J, Lake JR, Somberg K, Doherty C, Davila M, McQuaid K, Wall SD. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 126:858-65, 1997. e-Pub 1997. PMID: 9163286.

      Invited Articles

      1. Davila ML, Bresalier RS. Gastrointestinal complications of oncologic therapy. Nature Clinical Practice Gastroenterology & Hepatology 5(12):682-696, 2008. e-Pub 2008.
      2. Davila ML. Neutropenic enterocolitis: current issues in diagnosis and management. Curr Infect Dis Rep 9:116-20, 2007. e-Pub 2007. PMID: 17324348.
      3. Davila ML. Neutropenic enterocolitis. Curr Treat Options Gastroenterol 9(3):249-55, 2006. e-Pub 2006. PMID: 16901388.
      4. Davila ML. Neutropenic enterocolitis. Curr Opin Gastroenterol 22:44-7, 2006. e-Pub 2006. PMID: 16319675.
      5. Davila M, Beaulieu C, Paik O, Napel S, Edelstein P, Jeffrey R. CT and MR Colonography (Virtual Colonoscopy). Techniques in Gastrointestinal Endoscopy 2:30-36, 2000. e-Pub 2000.
      6. Davila M. Long-Term Follow-up after Endoscopic Sphincterotomy: Analysis of Sphincter Function, Bile Composition, and Bile Duct Histology. Adv Gastroenterol Hepatol Clin Nutr 3:23-26, 1998. e-Pub 1998.

      Professional Educational Materials

      1. Davila M. Sleisenger and Fordtran Gastrointestinal Disease Review and Assessment, Weisiger R, Bihartz L (eds). W.B. Saunders, 1995.

      Editorials

      1. Davila RE, Davila ML. Recent Advancements in the Diagnosis and Treatment of Gastrointestinal Cancers. Gastroenterol Clin North Am 51(3):xiii-xiv, 2022. PMID: 36153117.
      2. Davila ML, Davila RE. The demise of air insufflation and the rise of the warm water infusion method. Gastrointest Endosc 70(3):505-10, 2009.
      3. Thomas MB, Davila M, Abbruzzese JL. Stemming the Tide of Hepatitis B Virus-Related Hepatocellular Carcinoma?. Journal of Clinical Oncology 26:172-174, 2008.
      4. Davila M. Self-expanding metal stents in malignant colonic obstruction: have we covered all angles?. Gastrointest Endosc 66(5):937-9, 2007.

      Abstracts

      1. Chen, J, Chen JS, Zhang J, Gi YJ, Katz LH, Shin JH, Jeong YS, Belkin M, Jogunoori W, Mishra B, White J, Javle M, Su X, Stroehlein JR, Davila ML, Wang X, Morris J, Farci P, Akbani R, Mishra L. Integrated TGF-B Pathway Driven Functional Molecular Portrait of Human Hepatocellular Cancer. Gastroenterology 150(4):S1152-S1153, 2016. e-Pub 2016.
      2. Chen J, Shukla V, Panditab RK, Chen JS, Jeong YS, Katz LH, Shin JH, Gi YJ, Kwong LN, Huntb CR, Farci P, Su X, White J, Mishra B, Rashid A, Javle M, Li L, Chen J, Sgtroehlein JR, Davila ML, Akbani R, Machida K, Tsukamoto H, Pandita TJ, Mishra L. Dysregulated TGF-B Signaling Leads to Genomic Instability and Liver Cancer. Gastroenterology 150(4):S1152, 2016. e-Pub 2016.
      3. Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Qiao W, Ross W, Weston BR, Davila ML. Outcomes of Stent-in-Stent (SIS) in the Management of Malignant Distal Billary Obstruction (MDBO). Gastroenterology 150(4):S515-S516, 2016. e-Pub 2016.
      4. Chen J, Yao Z, Chen JS, Gi YJ, Jeong YS, Belkin M, Jogunoori W, Mishra B, White J, Mitra A, Li S, Finegold MJ, Davila ML, Shay J, Machida K, Tsukamoto H, Mishra L. A TGF-B-Ctcf Regulated Pathway Suppresses Stem Cell Associated Tumor Progression. Gastroenterology 150(4):S1153-1154, 2016. e-Pub 2016.
      5. Slack RS, Ross WA, Lum P, Thirumurthi S, Weston B, Miller E, Lee H, Shafi M, Davila M, Bresalier RS, Lynch PM, Shuttlesworth G, Mishra L, Stroehlein JR, Raju G. Reporting Adenoma Detection Rate Confidence Intervals Provide Better Feedback about Endoscopists' Performance. DDW 2015 - Accepted Abstracts:A-454, 2015. e-Pub 2015.
      6. Raju GS, Lum P, Lynch PM, Davila ML, Ross WA, Bhutani MS, Miller E, Lee J, Shafi MA, Thirumurthi S, Weston BR, Bresalier RS, Shuttlesworth G, Mishra L, Stroehlein JR. Outcomes of Management of Colon Polyps Larger Than 20 mm at a Referral Endoscopic Mucosal Resection Center. DDW 2015 - Accepted Abstracts:A-498, 2015. e-Pub 2015.
      7. Thirumurthuri S, Ross WA, Lum P, Pande M, Miller E, Lee J, Weston BR, Lynch PM, Davila ML, Bhutani MS, Shafi MA, Blechacs B, Bresalier RS, Stroehlein JR, Mishra L, Raju GS. When Patients Watch a Video, Physicians See More Adenomas: An Educational Bowel Preparation Video Improves Adenoma Detection Rates. DDW 2015 - Accepted Abstracts:A-475, 2015. e-Pub 2015.
      8. Miller E, Thirmurthuri S, Lim P, Pande M, Ross WA, Davila ML, Weston BR, Blechacz B, Bhutani MS, Lee J, Lynch PM, Shafi MA, Bresalier RS, Mishra L, Stroehlein JR, Raju GS. Five-Year Trends in Adenoma Detection Rates: A Report from a Single Academic Group Practice. DDW 2015 - Accepted Abstracts:A-463, 2015. e-Pub 2015.
      9. Raju GS, Lum P, Serna MK, Ross WA, Davila ML, Lynch PM, Thirurmurthi S, Lee J, Miller E, Bhutani MS, Rashid A, Shafi MA, Weston BR, Bresalier RS, Shuttlesworth G, Mishra L, Stroehlein JR. Outcome of Referral to an Endoscopic Mucosal Resection Center As an Alternative to Surgery in Patients with Large and Flat Colon Tumors. DDW 2015 - Accepted Abracts:A-327, 2015. e-Pub 2015.
      10. Menon VK, Raju GS, Chen J, Su X, Majumdar A, Shin J, Li S, Shetty K, Wu X, Weston BR, Miller E, Storehlein JR, Davila ML, Shafi MA, Rashid A, Kallakury BV, Thirumurthi S, McMurray JS, Lin S, Jogunoori W, Mishra L. The Genomic Landscape of Human Colon Adenomas Reveals Early Driver Mutations and a TGF-B-CEA Regulated Profile. Gastroenterology 148(4):S353-354, 2015. e-Pub 2015.
      11. Chen J, Chen J, Yao Z, Jogunoori W, Mishra B, Herlong F, Jeong YS, Mistry NA, Zhang J, Su X, Rashid A, Davila ML, Stroehlein JR, Shay JW, Mishra L. A TGF -B-CTCF Regulated Pathway Suppresses Stem Cell Associated Tumor Progression. Gastsroenterology 148(4):S-106, 2015. e-Pub 2015.
      12. Chouhan J, Cassani LS, Chan C, Lanke G, Lum P, Ross WA, Raju GS, Davila ML, Weston BR, Lee J. Endoscopic Versus Percutaneous Drainage for Management of Hilar Cholangiocarcinoma. Gastroenterology 148(4):S-964, 2015. e-Pub 2015.
      13. Chen J, Chen J, Zhang J, Gi Y, Phan LM, Munoz NM, Katz LH, Shin J, Jeong YS, Menon VK, Jogunoori W, Mishra B, Javle M, Su X, Farci P, Shetty K, Wu X, Hung M, Herlong F, Davila ML, Stroehlein JR, Shaw KR, Wang X, Morris JS, Akbani R, Mishra L. Prognostic Significance of TGF-B Signaling in Human Hepatocellular Carcinoma. Gastroenterology 148(4):S-1024, 2015. e-Pub 2015.
      14. Weston BR, Ross WA, Lum P, Thirumurthi S, Miller ED, Bhutani MS, Blechacz B, Bresalier RS, Davila ML, Dekovich AA, Guha S, Lee JH, Lynch PM, Pande M, Asif R, Shafi MA, Shuttlesworth G, Stack RS, Mishra L, Stroehlein JR, Raju GS. Adenoma Detection Rate (ADR) and Serrated Adenoma Detection Rate (SDR) During Screening Colonoscopy with and without a Personal Cancer History (PCH) in a Tertiary Referral Cancer Center. Gastrointestinal Endoscopy 79(5):AB202, 2014. e-Pub 2014.
      15. Raju GS, Ross WA, Lum P, Lynch PM, Slack RS, Miller E, Weston BR, Davila ML, Thirumurthi S, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Gua S, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR. Natural Language Processing (NLP) as an alternative to Manual Reporting of Colonoscopy Quality Metrics. Gastrointestinal Endoscopy 79(5):AB116-AB117, 5/2014 79(5):AB116-AB117, 2014. e-Pub 2014.
      16. Lum P, Ross WA, Pande M, Lynch PM, MIller ED, Bhutani MS, Weston BR, Thirumurthi S, Dekovich AA, Guha S, Shafi MA, Davila ML, Bresalier RS, Lee JH, Blechacz B, Shuttlesworth G, Mishra L, Stroehlein JR, Raju GS. . Measures to Improve Colonoscopy Quality Metrics. Gastrointestinal Endoscopy 79(5):AB201, 2014. e-Pub 2014.
      17. Thirumurthi S, Ross WA, Lum P, Miller E, Weston BR, Pande M, Lynch PM, Shafi M, Bhutani MS, Dekovich AA< Blechacz B, Lee JH, Davila ML, Bresalier RS, Slack RS, Guha S, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Raju GS. Adenoma Detection Rate & Sessile Serrated Adenoma Detection Rate Trends with Increasing Age: A Study Using a Natural Language Processing Computer Program. 1... Gastrointestinal Endoscopy 79(5):AB203, 2014. e-Pub 2014.
      18. Raju GS, Ross WA, Lum P, Lynch PM, Slack R, Miller E, Weston B, Davila ML, Thirumurthi S, Bhutani MS, Shafi M, Bresalier RS, Dekovich AA, Lee JH, Guha S, blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR. Natural Language Processing (NLP) as an alternative to manual reporting of colonoscopy quality metrics. DDW 2014, 2014. e-Pub 2014.
      19. Gavini H, Sheu-Woc W, Singh A, Ross WA, Ajani JA, Bhutani MS, Weston BR, Hofstetter WL, Davila ML, Raju Gottumukkala S, Welsh JW, Lee JH. Is a repeat endoscopy (EGD) necessary when referred for staging of newly diagnosed esophageal cancer?. DDW 2014, 2014. e-Pub 2014.
      20. Miller E, Ross WA, Lum P, Thirumurthi S, Weston BR, Pande M, Bhutani MS, Blechacz B, Bresalier RS, Davila ML, Dekovich AA, Guha S, Lee JH, Lynch PM, Shafi MA, Shuttlesworth G, Slack RS, Mishra L, Stroehlein JR, Raju GS. Gastrointestinal Endoscopy. Screening colonoscopy quality metrics for males and females across ethnic groups using a natural language processing algorithm 79(5):AB200-AB201, 2014. e-Pub 2014.
      21. Gavini H, Sheu-Woc W, Singh A, Ross WA, Ajani JA, Bhutani MS, Weston BR, Hofstetter WL, Davila ML, Raju GS, Welsh JW, Lee JH. Is a Repeat Endoscopy (EGD) NecessaryWhen Referred for Staging of Newly Diagnosed Esophageal Cancer?: A Comparison of Cancer Specialty Institution (CSI) with Other Institution (Osf). Gastroenterology 146(5):S511-S512, 2014. e-Pub 2014.
      22. Singh A, Bhattacharya A, Xiao L, Ross WA, Dekovich AA, Lee JE, Lynch PM, Davila ML, Krishna SG, Lee JH. Comparison of Gastrojejunostomy and Enteral SEMS in Management of Malignant Gastric Outlet Obstruction-A Single Tertiary Care Cancer Center Experience. DDW2013, 2013. e-Pub 2013.
      23. Thosani, NC, Davila ML. Upper GI-Small Bowel Imaging Poster Session. DDW 2012, 2012. e-Pub 2012.
      24. Shafi MA, Davila ML. Safety and efficacy of Radiofrequency Ablation in Post Esophagectomy Patients with residual or recurrent Barrett's: a tertiary cancer center experience. DDW 2012, 2012. e-Pub 2012.
      25. Vadyala V, Krishna SG, Walker L, Mahometano L, Davila ML, Lee JH, Ross WA, BHutani MS, Guha S, Stroehlein JR, Lynch PM, Raju GS. Clip closure after endoscopic mucosal resection (EMR) of > 20 mm lateral spreading tumors of the colon allows discharge of patients immediately after the procedure. ASGE DDW 2012, 2012. e-Pub 2012.
      26. Davila M, Mahale PS. The effect of transcatheter arterial chemoembolization on hepatitis C virus (HCV) kinetics in patients with HCV-associated hepatocellular carcinoma. ASCO Annual Meeting, 2011. e-Pub 2011.
      27. Torres HA, Davila, ML, Mulanovich VE, Granwehr BP, Miller E, Nevah MI, Mishra L, Kontoyiannis DP, Raad II. Hepatitis C Clinic at a Comprehensive Cancer Center: The successful story of multidisciplinary efforts. IDSA-49th annual meeting, 2011. e-Pub 2011.
      28. Torres, HA, Kaseb H, Davila M. The effect of transcatheter arterial chemoembolization on hepatitis C virus (HCV) kinetics in patients with HCV-associated hepatocellular carcinoma. J Clin Oncol suppl(e14578), 2011. e-Pub 2011.
      29. Torres HA, Mahale P, Davila M, Mulanovich V, Granwehr B, Kontoyiannis DP, Raad II. Hepatitis C Virus Infection in Cancer Patients: The Story of a Forgotten Population. 48th Annual IDSA Meeting, 2010. e-Pub 2010.
      30. Mahale P, Davila M, Chemaly RF, Lewis RE, Hwang JP, Kontoyiannis DP, Torres HA. Acute Exacerbation of Chronic Hepatitis C in Cancer Patients. 48th Annual IDSA Meeting, 2010. e-Pub 2010.
      31. Jafri SM, Biswas J, Arora G, Davila ML. Utility and Safety of Endoscopic Procedures in Neutropenic Patients with Gastrointestinal Bleeding. Gastro Endo 69(5):AB313, 2009. e-Pub 2009.
      32. Thosani N, Jafri SM, Dekovich AA, Ross WA, Dasari CS, Davila ML. Capsule Endoscopy in Patients with Low Neutrophil Count and Evidence of Gastrointestinal Bleeding. Gastro Endo 69(5):AB199, 2009. e-Pub 2009.
      33. Weston BR, Ross WA, Davila ML, and Lee JH. Clinical outcomes and performance of nitinol and stainless steel uncovered metal stents for malignant biliary strictures. Is there a difference?. Gastro Endo 67:AB170, 2008. e-Pub 2008.
      34. Lee JH, Davila RE, Ross WA, and Davila ML. Self-expandable metal stents in the management of benign and malignant colorectal obstruction. Gastro Endo 67:AB316, 2008. e-Pub 2008.
      35. Goetz GH, Lee JH, Davila M, Fukami N, Ross WA. Performance of Covered vs Uncovered metal stents in malignant stricture of the common duct. Gastro Endo 65:AB222, 2007. e-Pub 2007.
      36. Anandasabapathy S, Davila M, Wei C, Morris J, Bresalier R. Clinical and endoscopic factors predict higher pathologic grades of Barrett's Esophagus. Gastro 130/sup 2:A412, 2006. e-Pub 2006.
      37. Goetz D, Lee JH, Davila M, Fukami N, Ross W. Complications following endoscopic stent placement for malignant biliary obstruction: Preliminary Analysis. Gastro Endo 63:AB306, 2006. e-Pub 2006.
      38. Davila R, Davila M. Open Access Endoscopy: The experience at a tertiary care referral center. Gastro Endo 55:AB183, 2002. e-Pub 2002.
      39. Patti M, Davila M, Arcerito M, Feo C, Diener U, Triadafilopoulos G, Corley D, Gibbs V, Way L. Esophagectomy in patients with Barrett's High Grade Dysplasia. Gastroenterology 116:A278, 1999. e-Pub 1999.
      40. Patti M, Arcerito M, Tamburini A, Diener U, Triadafilopoulos G, Davila M, Vierra M, Feo C, Corley D, Gibbs V, Way L. Barrett's metaplasia is associated with worsening of the Gastroesophageal Reflux profile. Gastro 116:A278, 1999. e-Pub 1999.
      41. Davila M, Davila R, Triadafilopoulos G. Gastroesophageal Reflux Disease (GERD) in patients with and without Endoscopic Abnormalities: Age and Gender differences. Gastro Endo 47:A66, 1998. e-Pub 1998.

      Book Chapters

      1. Kassab C, Davila M, Hofstetter WL. Endoscopic Management of high grade dysplasia and superficial esophageal carcinoma. In: Shackelford’s Surgery for the Alimentary Tract. Elsevier Mosby, 2026.
      2. Hofstetter WL, Davila ML, Davila RE. Endoscopic Management of high grade dysplasia and superficial esophageal carcinoma. In: Shackelford’s Surgery for the Alimentary Tract. Elsevier Mosby, 2017.
      3. Davila ML, Hofstetter WL. Endoscopic Management of Barrett's Esophagus with High-Grade Dysplasia and Early-Stage Esophageal Adenocarcinoma. In: Evolving Therapies in Esophageal Carcinoma. Elsevier, 479-489, 2013.
      4. Davila ML, Torres HA. Management of Reactivation of Hepatitis B and Hepatitis C During Antineoplastic Therapy. In: Principles and Practice of Cancer Infectious Diseases. Humana Press, 189-194, 2011.
      5. Davila M, Torres HA. Management of Reactivation of Hepatitis C during antineoplastic therapy. In: Management of Infections in Cancer Patients. 1st Human Press, 2011.
      6. Davila M, Bresalier RS. Gastrointestinal Complications. In: Cancer Medicine. 7th. Holland-Frei, 2005.
      7. Schreiber J, Jeffrey R, Davila M, Beaulieu C. Spiral and Multidetector CT of the Large Intestine: Virtual Colonoscopy. In: Spiral CT. Lippincott-Raven, 2003.
      8. Davila M, Van Dam J. Photodynamic therapy for ablation of Barrett's esophagus. In: UpToDate. UpToDate, 2002.
      9. Davila M, Keeffe E. Complications of Endoscopy. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease. W.B. Saunders, 2002.
      10. Davila M. Irritable bowel syndrome. In: Pocket Medicine/Internal Medicine. PocketMedicine.com.Inc, 2001.
      11. Davila M. Foreign bodies and bezoars. In: Pocket Medicine/Internal Medicine. PocketMedicine.com.Inc, 2001.
      12. Davila M. Antibiotic-associated and Pseudomembranous colitis. In: Pocket Medicine/Internal Medicine. PocketMedicine.com.Inc, 2001.
      13. Davila M. Laxative Abuse. In: Pocket Medicine/Internal Medicine. PocketMedicine.com.Inc, 2001.
      14. Davila M. Screening for Sporadic Neoplasms. In: Protocols in General Surgery: Colon Cancer. John Wiley & Sons, Inc, 2000.
      15. Davila M, McQuaid K. Management of Rectal Foreign Bodies. In: Consultations in Gastroenterology. W.B. Saunders, 1995.

      Books (edited and written)

      1. Davila RE, Davila ML. Diagnosis and Treatment of Gastrointestinal Cancers. Ed(s) 3, 2022.

      Letters to the Editor

      1. Torres HA, Davila M. Current strategies in the management of hepatitis B virus reactivation. Nat Rev Clin Oncol, 2012.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 19, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top